We partner with the media to inform the public of the global human crisis.
Latest News
-
July 31, 2017
Indivior RBP-6000 NDA Acceptance with Priority Review Designation... -
July 31, 2017
Indivior’s NALSCUE® Receives Marketing Authorization from French Regulatory Agency ANSM... -
July 27, 2017
Indivior H1 2017 Financial Results... -
July 13, 2017
Indivior to Announce Half Year 2017 Results on July 27th... -
June 29, 2017
Reminder RBP-6000 Investor Event Announcement...
Global Media Contacts
Email: IndiviorMediaContacts@indivior.com
Phone: +1 804-594-0836
UK Media Contacts
Tulchan Communications LLP
85 Fleet Street
London
EC4Y 1AE
Indivior@Tulchangroup.com
Phone: +44 (020) 7353 4200
Upcoming Events
-
July 27th
H1 2017 Financial Results >
-
November 2nd
Q3 2017 Financial Results >
EMEA, Australasia and China Financial Disclosure Reporting
Disclosure Of Payments, Donations & Joint Working
Media Kit
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline